---
/**
 * QIF Pitch Presentation — Kohno Meeting
 * ~12 slides, 15-minute walkthrough, 15 min discussion
 * Reveal.js via CDN, styled with qinnovate design tokens
 */
import { HOURGLASS_BANDS, QIF_VERSION, QIF_BANDS, PILLARS, COHERENCE } from '../lib/qif-constants';
import { THREAT_VECTORS, getThreatStats, getTaraStats } from '../lib/threat-data';
import { NSP_VERSION } from '../lib/nsp-constants';

const stats = getThreatStats();
const taraStats = getTaraStats();

const dualUseCount = taraStats.dualUse.confirmed + taraStats.dualUse.probable;
const dualUsePct = Math.round((dualUseCount / taraStats.total) * 100);

// Resolve pillar CSS var colors to hex for inline styles
const colorMap: Record<string, string> = {
  'var(--color-accent-primary)': '#3b82f6',
  'var(--color-accent-secondary)': '#06b6d4',
  'var(--color-accent-tertiary)': '#8b5cf6',
};
function hex(c: string): string { return colorMap[c] ?? c; }
---

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>QIF Pitch | Qinnovate</title>
  <meta name="robots" content="noindex, nofollow" />

  <style is:global>
    @font-face {
      font-family: "Space Grotesk";
      src: url("/fonts/SpaceGrotesk-Variable.woff2") format("woff2");
      font-weight: 300 700;
      font-display: swap;
    }
    @font-face {
      font-family: "Inter";
      src: url("/fonts/Inter-Variable.woff2") format("woff2");
      font-weight: 100 900;
      font-display: swap;
    }
    @font-face {
      font-family: "JetBrains Mono";
      src: url("/fonts/JetBrainsMono-Variable.woff2") format("woff2");
      font-weight: 100 800;
      font-display: swap;
    }
  </style>

  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@5.1.0/dist/reveal.css" />
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@5.1.0/dist/theme/black.css" id="theme" />

  <style is:global>
    :root {
      --bg-deep: #0e1525;
      --bg-surface: #182038;
      --bg-elevated: #1e2a4a;
      --accent-primary: #3b82f6;
      --accent-secondary: #06b6d4;
      --accent-tertiary: #8b5cf6;
      --text-primary: #f1f5f9;
      --text-muted: #a8b8cf;
      --text-faint: #7289aa;
      --glass-bg: rgba(24, 32, 56, 0.65);
      --glass-border: rgba(255, 255, 255, 0.1);
      --safe: #10b981;
      --warn: #f59e0b;
      --danger: #ef4444;
    }

    .reveal-viewport { background: var(--bg-deep); }

    .reveal {
      font-family: "Inter", system-ui, sans-serif;
      color: var(--text-primary);
    }

    .reveal h1, .reveal h2, .reveal h3, .reveal h4 {
      font-family: "Space Grotesk", system-ui, sans-serif;
      color: var(--text-primary);
      text-transform: none;
      font-weight: 600;
      letter-spacing: -0.01em;
    }

    .reveal h1 { font-size: 2.4em; font-weight: 700; }
    .reveal h2 { font-size: 1.65em; font-weight: 600; }
    .reveal h3 { font-size: 1.15em; }

    .reveal p, .reveal li {
      color: var(--text-muted);
      line-height: 1.7;
      font-size: 0.88em;
    }

    .reveal code {
      font-family: "JetBrains Mono", ui-monospace, monospace;
      background: var(--bg-elevated);
      padding: 0.1em 0.35em;
      border-radius: 4px;
      font-size: 0.85em;
    }

    .reveal .progress { color: var(--accent-primary); height: 3px; }
    .reveal .controls button { color: var(--accent-primary); }
    .reveal .slide-number {
      color: var(--text-faint);
      font-family: "JetBrains Mono", monospace;
      font-size: 11px;
      background: transparent;
      right: 16px;
      bottom: 10px;
    }

    /* ═══ Components ═══ */

    .glass {
      background: var(--glass-bg);
      backdrop-filter: blur(16px) saturate(180%);
      -webkit-backdrop-filter: blur(16px) saturate(180%);
      border: 1px solid var(--glass-border);
      border-radius: 16px;
      padding: 24px;
      text-align: left;
    }

    .glass h3 { margin: 0 0 6px 0; font-size: 1em; }
    .glass p { margin: 0; font-size: 0.72em; color: var(--text-muted); }

    .tag {
      display: inline-block;
      font-family: "JetBrains Mono", monospace;
      font-size: 0.55em;
      padding: 2px 8px;
      border-radius: 6px;
      margin-bottom: 6px;
    }

    .mono { font-family: "JetBrains Mono", monospace; }
    .heading { font-family: "Space Grotesk", system-ui, sans-serif; }
    .faint { color: var(--text-faint); }
    .muted { color: var(--text-muted); }
    .accent { color: var(--accent-primary); }
    .cyan { color: var(--accent-secondary); }
    .purple { color: var(--accent-tertiary); }

    .label {
      font-family: "JetBrains Mono", monospace;
      font-size: 0.48em;
      text-transform: uppercase;
      letter-spacing: 0.12em;
      color: var(--text-faint);
      margin-bottom: 10px;
    }

    /* Stat cards */
    .stats { display: flex; gap: 14px; justify-content: center; margin-top: 24px; flex-wrap: wrap; }
    .stat {
      background: var(--glass-bg);
      border: 1px solid var(--glass-border);
      border-radius: 12px;
      padding: 14px 22px;
      text-align: center;
      min-width: 110px;
    }
    .stat .n {
      font-family: "Space Grotesk", system-ui;
      font-size: 1.9em;
      font-weight: 700;
      line-height: 1;
      margin-bottom: 3px;
    }
    .stat .l {
      font-size: 0.6em;
      color: var(--text-faint);
      text-transform: uppercase;
      letter-spacing: 0.06em;
    }

    /* Quote */
    .quote { max-width: 780px; margin: 0 auto; }
    .quote blockquote {
      border-left: 4px solid var(--accent-tertiary);
      padding: 14px 0 14px 24px;
      margin: 0;
      font-size: 1.05em;
      color: var(--text-primary);
      font-style: italic;
      line-height: 1.55;
      text-align: left;
    }
    .quote .cite {
      font-size: 0.6em;
      color: var(--text-faint);
      margin-top: 14px;
      font-style: normal;
      text-align: left;
      padding-left: 24px;
    }

    /* Grid layouts */
    .grid-3 { display: grid; grid-template-columns: repeat(3, 1fr); gap: 16px; margin-top: 24px; }
    .grid-2 { display: grid; grid-template-columns: 1fr 1fr; gap: 28px; align-items: start; text-align: left; }
    .grid-2 .span { grid-column: 1 / -1; text-align: center; }

    /* Band list */
    .bands { list-style: none; padding: 0; margin: 0; }
    .bands li { display: flex; align-items: center; gap: 8px; padding: 3px 0; font-size: 0.65em; }
    .dot { width: 9px; height: 9px; border-radius: 50%; flex-shrink: 0; }
    .bid { font-family: "JetBrains Mono", monospace; color: var(--text-primary); width: 26px; font-size: 0.9em; }
    .bname { color: var(--text-muted); }

    /* NSP layers */
    .layers { display: flex; flex-direction: column; gap: 7px; margin-top: 14px; }
    .layer {
      display: flex; align-items: center; gap: 10px;
      background: var(--glass-bg); border: 1px solid var(--glass-border);
      border-radius: 10px; padding: 9px 14px; font-size: 0.65em; text-align: left;
    }
    .layer .ln { font-family: "Space Grotesk", system-ui; font-weight: 700; font-size: 1.15em; min-width: 22px; color: var(--accent-secondary); }
    .layer .ll { color: var(--text-primary); font-weight: 500; }
    .layer .ls { color: var(--text-faint); font-size: 0.85em; margin-left: auto; }

    /* Dual-use mapping */
    .dualmap { display: grid; grid-template-columns: 1fr auto 1fr; gap: 10px 16px; align-items: center; font-size: 0.72em; }
    .dualmap .a { text-align: right; color: var(--danger); }
    .dualmap .arrow { color: var(--accent-secondary); font-size: 1.1em; }
    .dualmap .t { text-align: left; color: var(--safe); }

    /* Honest list */
    .gaps { text-align: left; max-width: 680px; margin: 16px auto 0; }
    .gaps li { margin-bottom: 10px; font-size: 0.75em; padding-left: 6px; }
    .gaps li strong { color: var(--text-primary); }

    /* Research questions */
    .questions { text-align: left; max-width: 700px; margin: 16px auto 0; }
    .questions li {
      position: relative; padding-left: 18px; margin-bottom: 14px; font-size: 0.72em;
    }
    .questions li::before {
      content: ''; position: absolute; left: 0; top: 7px;
      width: 7px; height: 7px; border-radius: 50%; background: var(--accent-primary);
    }
    .questions li strong { color: var(--text-primary); }
    .questions li em { color: var(--text-faint); font-size: 0.9em; }

    /* Contact */
    .links { display: flex; gap: 16px; justify-content: center; margin-top: 20px; flex-wrap: wrap; }
    .link {
      background: var(--glass-bg); border: 1px solid var(--glass-border);
      border-radius: 10px; padding: 10px 18px;
      color: var(--text-primary); text-decoration: none; font-size: 0.7em;
      transition: border-color 0.2s, transform 0.2s;
    }
    .link:hover { border-color: var(--accent-primary); transform: translateY(-2px); }

    /* Fragment fade-in tweak */
    .reveal .fragment { transition: all 0.3s ease; }

    /* ═══ Music toggle ═══ */
    .music-toggle {
      position: fixed;
      bottom: 16px;
      left: 16px;
      z-index: 100;
      width: 36px;
      height: 36px;
      border-radius: 50%;
      background: var(--glass-bg);
      border: 1px solid var(--glass-border);
      backdrop-filter: blur(12px);
      -webkit-backdrop-filter: blur(12px);
      color: var(--text-faint);
      cursor: pointer;
      display: flex;
      align-items: center;
      justify-content: center;
      transition: border-color 0.3s, color 0.3s, box-shadow 0.3s;
    }
    .music-toggle:hover {
      border-color: var(--accent-secondary);
      color: var(--accent-secondary);
    }
    .music-toggle.playing {
      border-color: var(--accent-secondary);
      color: var(--accent-secondary);
      box-shadow: 0 0 12px rgba(6, 182, 212, 0.25);
    }
    .music-toggle svg { width: 16px; height: 16px; }
    .music-toggle .icon-pause { display: none; }
    .music-toggle.playing .icon-play { display: none; }
    .music-toggle.playing .icon-pause { display: block; }

    #sc-player { position: absolute; left: -9999px; width: 1px; height: 1px; }

    @media (max-width: 768px) {
      .grid-3 { grid-template-columns: 1fr; }
      .grid-2 { grid-template-columns: 1fr; }
      .stats { flex-direction: column; align-items: center; }
    }
  </style>
</head>
<body>
  <div class="reveal">
    <div class="slides">

      <!-- ═══ 1. TITLE ═══ -->
      <section>
        <p class="label">Qinnovate &mdash; Open Standards for Neural Security</p>
        <h1 style="margin-bottom: 0;">QIF</h1>
        <p style="font-size: 1.05em; color: var(--accent-secondary); margin-top: 6px;" class="heading">
          Security Architecture for the Neural Stack
        </p>
        <div style="margin-top: 32px;">
          <p style="font-size: 0.7em; color: var(--text-primary); margin: 0;">Kevin Qi</p>
          <p style="font-size: 0.5em; margin-top: 4px;" class="faint">
            qinnovate.com &nbsp;|&nbsp; v{QIF_VERSION} &nbsp;|&nbsp; Apache 2.0
          </p>
        </div>
        <aside class="notes">
          Thank you for making time. I know your schedule is demanding, so I'll keep this tight
          and leave plenty of room for your questions. I'm here to learn from you, not to sell anything.
        </aside>
      </section>

      <!-- ═══ 2. THE ORIGIN — Kohno's own words ═══ -->
      <section>
        <p class="label">Neurosurgical Focus, 2009</p>
        <div class="quote">
          <blockquote>
            "Neurosecurity is a term we are using to refer to security, privacy,
            and ethical issues related to neural devices."
          </blockquote>
          <p class="cite">
            Denning, Matsuoka &amp; <strong>Kohno</strong><br />
            <em>Neurosecurity: Security and Privacy for Neural Devices</em><br />
            Neurosurgical Focus 27(1):E7, July 2009
          </p>
        </div>
        <p style="font-size: 0.7em; margin-top: 24px; max-width: 600px; margin-left: auto; margin-right: auto;">
          You coined the term. You defined the field.<br />
          I've been trying to build the architecture you called for.
        </p>
        <aside class="notes">
          This is the paper that started everything for me. You, Denning, and Matsuoka
          literally named the field. I've been working to build the technical scaffolding
          underneath that vision.
        </aside>
      </section>

      <!-- ═══ 3. THE GAP ═══ -->
      <section>
        <h2>16 Years Later</h2>
        <p style="max-width: 620px; margin: 10px auto 0;">
          The community produced excellent point solutions but no unifying structure.
        </p>
        <div class="stats">
          <div class="stat">
            <div class="n" style="color: var(--warn);">~20</div>
            <div class="l">Published BCI<br />attack papers</div>
          </div>
          <div class="stat">
            <div class="n" style="color: var(--danger);">0</div>
            <div class="l">Unified threat<br />frameworks</div>
          </div>
          <div class="stat">
            <div class="n" style="color: var(--danger);">0</div>
            <div class="l">Wire-level<br />BCI crypto</div>
          </div>
          <div class="stat">
            <div class="n" style="color: var(--danger);">0</div>
            <div class="l">Post-quantum<br />neural protocols</div>
          </div>
        </div>
        <p style="font-size: 0.55em; margin-top: 20px;" class="faint">
          Martinovic 2012 &middot; Takabi 2016 &middot; Frank 2017 &middot; Bernal 2021 &middot; Landau 2020 &middot; Meng 2023
        </p>
        <aside class="notes">
          Martinovic showed P300 side-channels in 2012. Takabi catalogued BCI threats.
          Frank demonstrated EEG spoofing. But nobody built a unified model that
          accounts for both the silicon and the biology. That's the gap.
        </aside>
      </section>

      <!-- ═══ 4. WHAT I BUILT — Three Pillars ═══ -->
      <section>
        <h2>What I Built</h2>
        <p style="max-width: 520px; margin: 4px auto 0;">
          Three interlocking open specifications.
        </p>
        <div class="grid-3">
          {PILLARS.map(p => {
            const c = hex(p.color);
            return (
            <div class="glass">
              <span class="tag" style={`background: ${c}20; color: ${c}; border: 1px solid ${c}40;`}>
                {p.name} v{p.version}
              </span>
              <h3 style={`color: ${c};`}>{p.fullName}</h3>
              <p>{p.tagline}</p>
              <p style="margin-top: 6px; font-size: 0.62em;" class="faint">{p.description}</p>
            </div>
          )})}
        </div>
        <aside class="notes">
          QIF is the threat model. NSP is the wire protocol. Runemate solves the bandwidth
          problem that makes post-quantum encryption practical on implantable power budgets.
          All three are open spec, Apache 2.0. I don't want to sell certifications. I want
          the field to adopt this.
        </aside>
      </section>

      <!-- ═══ 5. THE HOURGLASS ═══ -->
      <section>
        <div class="grid-2">
          <div class="span">
            <h2>The Hourglass Model</h2>
            <p style="font-size: 0.72em; max-width: 580px; margin: 4px auto 0;">
              {QIF_BANDS} bands across three zones. The OSI model couldn't represent tissue,
              so I built one that does.
            </p>
          </div>
          <div>
            <ul class="bands">
              {HOURGLASS_BANDS.map(b => (
                <li>
                  <span class="dot" style={`background: ${b.color};`}></span>
                  <span class="bid">{b.id}</span>
                  <span class="bname">{b.name}</span>
                </li>
              ))}
            </ul>
          </div>
          <div>
            <div class="glass" style="padding: 14px 18px;">
              <h3 style="font-size: 0.8em; color: var(--safe); margin-bottom: 4px;">Neural (N7-N1)</h3>
              <p style="font-size: 0.62em;">Biology. Cannot be patched or rebooted.</p>
            </div>
            <div class="glass" style="padding: 14px 18px; margin-top: 8px;">
              <h3 style="font-size: 0.8em; color: var(--warn); margin-bottom: 4px;">Interface (I0)</h3>
              <p style="font-size: 0.62em;">The waist. Electrode-tissue boundary. Where physics changes.</p>
            </div>
            <div class="glass" style="padding: 14px 18px; margin-top: 8px;">
              <h3 style="font-size: 0.8em; color: var(--accent-primary); margin-bottom: 4px;">Synthetic (S1-S3)</h3>
              <p style="font-size: 0.62em;">Silicon. Can encrypt, can patch, can monitor.</p>
            </div>
          </div>
        </div>
        <aside class="notes">
          The key insight: the hourglass pinches at I0, the electrode-tissue boundary.
          Above it, you're in biology where you can't deploy patches. Below it, you're
          in silicon where classical security tools work. The interface layer is where
          the hardest problems live, and it's where your 2009 paper focused.
        </aside>
      </section>

      <!-- ═══ 6. THREAT TAXONOMY ═══ -->
      <section>
        <h2>Threat Taxonomy</h2>
        <p style="max-width: 580px; margin: 8px auto 0;">
          MITRE ATT&CK for neural interfaces. Every technique mapped to hourglass bands,
          scored across six impact dimensions.
        </p>
        <div class="stats">
          <div class="stat">
            <div class="n accent">{stats.total}</div>
            <div class="l">Techniques</div>
          </div>
          <div class="stat">
            <div class="n cyan">{QIF_BANDS}</div>
            <div class="l">Hourglass<br />bands</div>
          </div>
          <div class="stat">
            <div class="n" style="color: var(--danger);">{stats.critical}</div>
            <div class="l">Critical<br />severity</div>
          </div>
          <div class="stat">
            <div class="n purple">6</div>
            <div class="l">QNIS scoring<br />dimensions</div>
          </div>
        </div>
        <p style="font-size: 0.52em; margin-top: 18px;" class="faint">
          Live at qinnovate.com/TARA &mdash; filterable by band, severity, tactic, and dual-use classification
        </p>
        <aside class="notes">
          Every technique has a QNIS score, like CVSS but for neural systems. It scores
          across reversibility, cognitive impact, tissue risk, consent requirements, and
          two more dimensions. The whole registry is browsable on the site.
        </aside>
      </section>

      <!-- ═══ 7. NSP PROTOCOL ═══ -->
      <section>
        <h2>NSP: The Wire Protocol</h2>
        <p style="max-width: 580px; margin: 8px auto 0;">
          Post-quantum cryptography for BCI data streams. FIPS 203/204/205 compliant.
        </p>
        <div class="layers" style="max-width: 660px; margin: 16px auto 0;">
          <div class="layer"><span class="ln">L1</span><span class="ll">Hardware Root of Trust</span><span class="ls">SPHINCS+ boot</span></div>
          <div class="layer"><span class="ln">L2</span><span class="ll">Hybrid PQC Key Exchange</span><span class="ls">ML-KEM + ECDH</span></div>
          <div class="layer"><span class="ln">L3</span><span class="ll">QI Signal Integrity</span><span class="ls">Per-frame scoring</span></div>
          <div class="layer"><span class="ln">L4</span><span class="ll">Adaptive Detection</span><span class="ls">Test-time training</span></div>
          <div class="layer"><span class="ln">L5</span><span class="ll">Emergency Shutoff</span><span class="ls">Hardware kill switch</span></div>
        </div>
        <div class="stats" style="margin-top: 16px;">
          <div class="stat">
            <div class="n cyan">3.25%</div>
            <div class="l">Power<br />overhead</div>
          </div>
          <div class="stat">
            <div class="n cyan">v{NSP_VERSION}</div>
            <div class="l">Draft RFC</div>
          </div>
        </div>
        <aside class="notes">
          The power budget is modeled, not measured. 3.25% of a 10mW implantable budget.
          That's the theoretical ceiling. Runemate compression is what makes PQC key sizes
          practical at BCI bandwidths. I'd love your take on whether these constraints are
          realistic for implantable devices.
        </aside>
      </section>

      <!-- ═══ 8. THE DUAL-USE DISCOVERY ═══ -->
      <section>
        <h2>The Discovery That Changed Everything</h2>
        <p style="max-width: 620px; margin: 10px auto 0;">
          I started cataloguing attacks. The same physical mechanisms kept appearing
          on the therapeutic side.
        </p>
        <div style="margin-top: 20px;">
          <p style="font-size: 0.88em; color: var(--text-primary); line-height: 1.7;">
            Signal injection is also deep brain stimulation.<br />
            Replay attacks share physics with neurofeedback.<br />
            <strong style="color: var(--accent-secondary);">The difference is consent, dosage, and oversight.</strong>
          </p>
        </div>
        <div style="margin-top: 24px;">
          <p class="mono" style="font-size: 0.6em; color: var(--accent-secondary);">
            TARA &mdash; Therapeutic Atlas of Risks and Applications
          </p>
          <p style="font-size: 0.55em; margin-top: 4px;" class="faint">
            Same mechanism. Four projections: Security / Clinical / Governance / Engineering
          </p>
        </div>
        <aside class="notes">
          This is the part I think connects most to your current work at the Center for
          Digital Ethics. The security framework became a dual-use map. The same physics
          that makes an attack dangerous makes a therapy effective. The distinguishing
          variables are ethical, not physical: informed consent, dosage control, clinical
          oversight. That's a governance problem, not just an engineering problem.
        </aside>
      </section>

      <!-- ═══ 9. DUAL-USE MAPPING ═══ -->
      <section>
        <h2>Dual-Use Mapping</h2>
        <p style="max-width: 580px; margin: 8px auto 0;">
          ~{dualUsePct}% of catalogued techniques have therapeutic analogs today.
          The gap is the research agenda.
        </p>
        <div class="dualmap" style="max-width: 560px; margin: 20px auto 0;">
          <span class="a">Signal injection</span><span class="arrow">&rarr;</span><span class="t">Deep brain stimulation</span>
          <span class="a">Phase replay</span><span class="arrow">&rarr;</span><span class="t">Neurostimulation protocols</span>
          <span class="a">Adversarial perturbation</span><span class="arrow">&rarr;</span><span class="t">Seizure suppression</span>
          <span class="a">Slow drift manipulation</span><span class="arrow">&rarr;</span><span class="t">Adaptive neuromodulation</span>
          <span class="a">EM side-channel</span><span class="arrow">&rarr;</span><span class="t">TMS / tDCS diagnostics</span>
        </div>
        <div class="stats" style="margin-top: 20px;">
          <div class="stat">
            <div class="n" style="color: var(--safe);">{taraStats.dualUse.confirmed}</div>
            <div class="l">Confirmed</div>
          </div>
          <div class="stat">
            <div class="n cyan">{taraStats.dualUse.probable}</div>
            <div class="l">Probable</div>
          </div>
          <div class="stat">
            <div class="n faint">{taraStats.dualUse.silicon_only}</div>
            <div class="l">Silicon only</div>
          </div>
          <div class="stat">
            <div class="n" style="color: var(--safe);">{taraStats.clinicalCount}</div>
            <div class="l">Clinical data</div>
          </div>
        </div>
        <aside class="notes">
          31 confirmed, 15 probable. 16 are silicon-only with no therapeutic mapping today.
          That gap is honest. Some attack vectors might never have therapeutic analogs, and
          I don't want to overclaim. But the pattern is strong enough that I think the
          framework itself is a useful tool for thinking about both sides simultaneously.
        </aside>
      </section>

      <!-- ═══ 10. WHERE IT BREAKS ═══ -->
      <section>
        <h2>Where It Breaks</h2>
        <p style="max-width: 580px; margin: 8px auto 0;">
          What I don't know. Where I need help.
        </p>
        <ul class="gaps" style="list-style: none; padding: 0;">
          <li>
            <strong style="color: var(--warn);">No empirical validation.</strong>
            Derived from literature and first principles. Needs testing against real BCI
            hardware and patient data.
          </li>
          <li>
            <strong style="color: var(--warn);">Power budget is modeled, not measured.</strong>
            3.25% overhead on paper. Needs silicon prototyping.
          </li>
          <li>
            <strong style="color: var(--warn);">~40% of techniques have no therapeutic analog.</strong>
            The dual-use claim has real limits. I've scoped them explicitly.
          </li>
          <li>
            <strong style="color: var(--warn);">Solo researcher with AI verification.</strong>
            Claude and Gemini helped validate, but I have no wet-lab collaborators and no
            access to patient data.
          </li>
        </ul>
        <aside class="notes">
          I want to be completely honest with you about what this is and what it isn't.
          It's a framework, not a product. It's derived, not empirical. I've tried to be
          rigorous about scoping claims, but I know the biggest thing missing is contact
          with reality. That's what I'm hoping to get help with.
        </aside>
      </section>

      <!-- ═══ 11. WHAT I'M LOOKING FOR ═══ -->
      <section>
        <h2>What I'd Like to Explore Together</h2>
        <ul class="questions" style="list-style: none; padding: 0;">
          <li>
            <strong>Does the hourglass model hold?</strong><br />
            <em>Does an 11-band architecture meaningfully capture the BCI threat surface,
            or are there gaps the model misses?</em>
          </li>
          <li>
            <strong>Can TARA inform governance?</strong><br />
            <em>Your Center for Digital Ethics focus: could a dual-use registry help
            regulators distinguish therapeutic vs. adversarial use of the same mechanism?</em>
          </li>
          <li>
            <strong>Is the NSP power budget realistic?</strong><br />
            <em>3.25% on a 10mW implant. Is that feasible, or does PQC on-device need
            a fundamentally different approach?</em>
          </li>
          <li>
            <strong>Where should I go next?</strong><br />
            <em>Graduate program, industry lab, independent research? I want your honest
            assessment of the most productive path forward.</em>
          </li>
        </ul>
        <aside class="notes">
          These aren't hypothetical questions. I genuinely don't know the answers, and
          you're one of the few people in the world who can help me think through them.
          The last question is personal. I'm trying to figure out the right path to make
          the most impact with this work.
        </aside>
      </section>

      <!-- ═══ 12. THANK YOU ═══ -->
      <section>
        <p class="label">Thank you</p>
        <h2 style="margin-bottom: 6px;">You named this field.<br />I'd like to help build it.</h2>
        <p style="font-size: 0.75em; max-width: 480px; margin: 10px auto 0;">
          Everything is open. I'm looking for mentorship, not funding.
          Point me in the right direction and I'll do the work.
        </p>
        <div class="links" style="margin-top: 28px;">
          <a class="link" href="https://qinnovate.com" target="_blank">qinnovate.com</a>
          <a class="link" href="https://qinnovate.com/framework/" target="_blank">Framework</a>
          <a class="link" href="https://qinnovate.com/TARA/" target="_blank">TARA Atlas</a>
          <a class="link" href="https://github.com/qinnovates" target="_blank">GitHub</a>
        </div>
        <p style="font-size: 0.5em; margin-top: 28px;" class="faint">
          Kevin Qi &nbsp;|&nbsp; Qinnovate &nbsp;|&nbsp; Open Standard &nbsp;|&nbsp; Apache 2.0
        </p>
        <aside class="notes">
          Thank you. I mean this sincerely. Your 2009 paper is why this work exists.
          Everything is public, everything is open source. I'm not selling anything.
          I'm asking for guidance from someone who's been thinking about this longer
          than almost anyone.
        </aside>
      </section>

    </div>
  </div>

  <!-- Music toggle -->
  <button class="music-toggle" id="music-toggle" title="Toggle music">
    <svg class="icon-play" viewBox="0 0 24 24" fill="currentColor"><polygon points="6,3 20,12 6,21" /></svg>
    <svg class="icon-pause" viewBox="0 0 24 24" fill="currentColor"><rect x="5" y="3" width="4" height="18" /><rect x="15" y="3" width="4" height="18" /></svg>
  </button>

  <!-- SoundCloud Widget (hidden) -->
  <iframe id="sc-player"
    scrolling="no" frameborder="no" allow="autoplay"
    src="https://w.soundcloud.com/player/?url=https%3A//soundcloud.com/keviano/kulhi-loach&auto_play=false&hide_related=true&show_comments=false&show_user=false&show_reposts=false&show_teaser=false&visual=false">
  </iframe>

  <script is:inline src="https://cdn.jsdelivr.net/npm/reveal.js@5.1.0/dist/reveal.js"></script>
  <script is:inline src="https://cdn.jsdelivr.net/npm/reveal.js@5.1.0/plugin/notes/notes.js"></script>
  <script is:inline>
    Reveal.initialize({
      hash: true,
      slideNumber: 'c/t',
      showSlideNumber: 'all',
      width: 1280,
      height: 720,
      margin: 0.07,
      transition: 'fade',
      transitionSpeed: 'fast',
      center: true,
      controls: true,
      controlsLayout: 'edges',
      progress: true,
      history: true,
      keyboard: true,
      overview: true,
      touch: true,
      plugins: [ RevealNotes ],
    });
  </script>

  <!-- SoundCloud Widget API -->
  <script is:inline src="https://w.soundcloud.com/player/api.js"></script>
  <script is:inline>
    (function() {
      var toggle = document.getElementById('music-toggle');
      var iframe = document.getElementById('sc-player');
      var widget = null;
      var widgetReady = false;
      var isPlaying = false;
      var pendingPlay = false;

      function initWidget() {
        if (typeof SC === 'undefined' || !SC.Widget) {
          setTimeout(initWidget, 100);
          return;
        }
        widget = SC.Widget(iframe);
        widget.bind(SC.Widget.Events.READY, function() {
          widgetReady = true;
          widget.setVolume(40);
          if (pendingPlay) {
            pendingPlay = false;
            widget.play();
          }
        });
        widget.bind(SC.Widget.Events.PLAY, function() {
          isPlaying = true;
          toggle.classList.add('playing');
        });
        widget.bind(SC.Widget.Events.PAUSE, function() {
          isPlaying = false;
          toggle.classList.remove('playing');
        });
        widget.bind(SC.Widget.Events.FINISH, function() {
          widget.seekTo(0);
          widget.play();
        });
        widget.bind(SC.Widget.Events.ERROR, function() {
          isPlaying = false;
          toggle.classList.remove('playing');
        });
      }

      toggle.addEventListener('click', function(e) {
        e.stopPropagation();
        e.preventDefault();
        if (!widgetReady || !widget) {
          pendingPlay = true;
          toggle.classList.add('playing');
          return;
        }
        if (isPlaying) {
          widget.pause();
        } else {
          widget.play();
        }
      });

      initWidget();
    })();
  </script>
</body>
</html>
